| Diverse effects of hepatic steatosis on fibrosis progression and functional cure in virologically quiescent chronic hepatitis B LY Mak, RWH Hui, J Fung, F Liu, DKH Wong, KS Cheung, MF Yuen, ... Journal of hepatology 73 (4), 800-806, 2020 | 126 | 2020 |
| Coffee consumption decreases risks for hepatic fibrosis and cirrhosis: a meta-analysis F Liu, X Wang, G Wu, L Chen, P Hu, H Ren, H Hu PloS one 10 (11), e0142457, 2015 | 108 | 2015 |
| Systematic review with meta‐analysis: development of hepatocellular carcinoma in chronic hepatitis B patients with hepatitis B surface antigen seroclearance F Liu, XW Wang, L Chen, P Hu, H Ren, HD Hu Alimentary pharmacology & therapeutics 43 (12), 1253-1261, 2016 | 102 | 2016 |
| Role of hepatitis B core protein in HBV transcription and recruitment of histone acetyltransferases to cccDNA minichromosome CK Chong, CYS Cheng, SYJ Tsoi, FY Huang, F Liu, WK Seto, CL Lai, ... Antiviral research 144, 1-7, 2017 | 73 | 2017 |
| Interferon-based anti-viral therapy for hepatitis C virus infection after renal transplantation: an updated meta-analysis F Wei, J Liu, F Liu, H Hu, H Ren, P Hu PLoS One 9 (4), e90611, 2014 | 50 | 2014 |
| Peginterferon is preferable to entecavir for prevention of unfavourable events in patients with HBeAg‐positive chronic hepatitis B: a five‐year observational cohort study SY Li, H Li, YL Xiong, F Liu, ML Peng, DZ Zhang, H Ren, P Hu Journal of viral hepatitis 24, 12-20, 2017 | 38 | 2017 |
| Reduced hepatic steatosis is associated with higher risk of hepatocellular carcinoma in chronic hepatitis B infection LY Mak, RWH Hui, J Fung, F Liu, DKH Wong, B Li, KS Cheung, MF Yuen, ... Hepatology International 15 (4), 901-911, 2021 | 36 | 2021 |
| Hepatitis B core‐related antigen levels after HBeAg seroconversion is associated with the development of hepatocellular carcinoma WP To, LY Mak, DKH Wong, J Fung, F Liu, WK Seto, CL Lai, MF Yuen Journal of Viral Hepatitis 26 (12), 1473-1480, 2019 | 32 | 2019 |
| Efficacy and resistance in de novo combination lamivudine and adefovir dipivoxil therapy versus entecavir monotherapy for the treatment-naive patients with chronic hepatitis B … F Liu, X Wang, F Wei, H Hu, D Zhang, P Hu, H Ren Virology journal 11, 1-11, 2014 | 31 | 2014 |
| HBV X protein mutations affect HBV transcription and association of histone-modifying enzymes with covalently closed circular DNA CK Chong, CYS Cheng, SYJ Tsoi, FY Huang, F Liu, J Fung, WK Seto, ... Scientific Reports 10 (1), 802, 2020 | 25 | 2020 |
| Association of adipokines with hepatic steatosis and fibrosis in chronic hepatitis B patients on long‐term nucleoside analogue LY Mak, CH Lee, KS Cheung, DKH Wong, F Liu, RWH Hui, J Fung, A Xu, ... Liver International 39 (7), 1217-1225, 2019 | 20 | 2019 |
| Serum Mac-2 binding protein glycosylation isomer level predicts hepatocellular carcinoma development in E-negative chronic hepatitis B patients LY Mak, WP To, DKH Wong, J Fung, F Liu, WK Seto, CL Lai, MF Yuen World Journal of Gastroenterology 25 (11), 1398, 2019 | 20 | 2019 |
| Intestinal strictures in Crohn’s disease: a 2021 update X Lin, Y Wang, Z Liu, S Lin, J Tan, J He, F Hu, X Wu, S Ghosh, M Chen, ... Therapeutic Advances in Gastroenterology 15, 17562848221104951, 2022 | 19 | 2022 |
| Efficacy and safety of pegylated interferon plus ribavirin therapy for chronic hepatitis C genotype 6: a meta-analysis X Wang, F Liu, F Wei, H Ren, H Hu PLoS One 9 (6), e100128, 2014 | 19 | 2014 |
| Cellular and molecular mechanisms of intestinal fibrosis X Wu, X Lin, J Tan, Z Liu, J He, F Hu, Y Wang, M Chen, F Liu, R Mao Gut and Liver 17 (3), 360, 2023 | 13 | 2023 |
| Intestinal stricture in Crohn's disease: A 2020 update XX Lin, Y Qiu, XJ Zhuang, F Liu, XM Wu, MH Chen, R Mao Journal of Digestive Diseases 22 (7), 390-398, 2021 | 13 | 2021 |
| Down-regulation of colonic ACE2 expression in patients with inflammatory bowel disease responding to anti-TNF therapy: implications for COVID-19 XZ Li, Y Qiu, L Jeffery, F Liu, R Feng, JS He, JY Tan, ZY Ye, SN Lin, ... Frontiers in medicine 7, 613475, 2021 | 12 | 2021 |
| Role of Serum M2BPGi levels in predicting persistence of advanced fibrosis in chronic hepatitis B virus infection LY Mak, DKH Wong, KS Cheung, RWH Hui, F Liu, J Fung, WK Seto, ... Digestive diseases and sciences 67 (11), 5127-5136, 2022 | 7 | 2022 |
| Phenotypic changes of PD-1 and GITR in T cells are associated with hepatitis b surface antigen seroclearance F Liu, S Zhang, DKH Wong, FY Huang, KS Cheung, LY Mak, J Fung, ... Journal of Clinical Gastroenterology 56 (1), e31-e37, 2022 | 6 | 2022 |
| A model with combined viral and metabolic factors effectively predicts HBeAg status under long term entecavir therapy: a prospective cohort study F Liu, F Zou, X Wang, H Hu, P Hu, H Ren Virology Journal 12, 1-10, 2015 | 5 | 2015 |
